Work

Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors

Year: 2026

Type: article

Source: Leukemia

DOI: 10.1038/s41375-026-02982-7

Authors: Aditi Chatterjee, Moaath K. Mustafa Ali, Christopher M. Bailey, Yuchen Liu, Donald Small, Catherine C. Smith, Elie Traer, Yin Wang, Giovannino Silvestri, Maria R. Baer

Institutions: University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Oregon Health & Science University, OHSU Knight Cancer Institute, University of Maryland Medical Center, Veterans Health Administration, Baltimore VA Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, U.S. Department of Veterans Affairs, Damon Runyon Cancer Research Foundation, National Institutes of Health, National Cancer Institute, Moonshot Research and Development Program, Cancer Moonshot

Awards: G1165598027, G3989231266, G4514864751, G5712941862, G620709104, G821304228, UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT, Architecture and Trajectory of Acquired Resistance to Therapy in AML, Training Grant in Cancer Biology

OpenAlex ID: W4416716464

FWCI: 8.835

Cites: 44

Cited by: 2

Related to: